Global /China /Healthcare /Drug Manufacturers - General /002755

Beijing Aosaikang Pharmaceutical Co., Ltd.

002755

• SHE: 002755 • Delayed

16.95CNY 4.6%

2.50 USD

As of 16 June 2026, Beijing Aosaikang Pharmaceutical Co., Ltd. has a market cap of $2.32B USD, ranking #6401 globally and #1481 in China. It ranks #504 in the Healthcare sector, and #194 in the Drug Manufacturers - General industry.

Global Rank

6401

Country Rank

1481

Sector Rank

504

Industry Rank

194

Key Stats

Market Cap

$2.32BUSD

15.73B CNY

Enterprise Value

$1.97BUSD

13.34B CNY

Revenue (TTM)

$258.93MUSD

1.75B CNY

EBITDA (TTM)

$64.6MUSD

437.15M CNY

Net Income (TTM)

$39.36MUSD

266.34M CNY

EBITDA Margin

25%

Profit Margin

15%

PE Ratio

60.6

PS Ratio

9.0

PB Ratio

4.7

EV/EBITDA

30.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jingfei Ma open_in_new

Employees

988

Founded

2003

Website

ask-pharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
4.6%	-0.8%	5.3%	-1.8%	-14%	-0.7%	-14%	44%	11%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002755 北京奥赛康药业股份有限公司 Class A ISIN: CNE100001X92 Shares Out.: Shares Outstanding: 928.16M¹ Shares Float: 655.707M² TV: TradingView: SZSE: 002755 SA: Stock Analysis: SHE: 002755 YF: Yahoo Finance: 002755.SZ GF: Google Finance: SHE: 002755 BA: Barron's: 002755 MS: Morningstar: XSHE: 002755	16.95 CNY	TV: TradingView: SZSE: 002755 SA: Stock Analysis: SHE: 002755 YF: Yahoo Finance: 002755.SZ GF: Google Finance: SHE: 002755 BA: Barron's: 002755 MS: Morningstar: XSHE: 002755

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Beijing Aosaikang Pharmaceutical Co., Ltd.

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.92B 364.89B CNY 2K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.7B 336.36B CNY 2K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 1K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 709%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 611%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 589%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 33K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 23K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 15K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 14K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 12K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 12K%	15.1	United States

chevron_leftBack